Management of Tachycardia with HR 180 bpm
Adenosine is the drug of choice to rapidly convert a patient with a heart rate of 180 bpm to sinus rhythm. 1
Mechanism of Action and Efficacy
Adenosine works by temporarily blocking the AV node, interrupting the reentrant circuit that maintains many forms of supraventricular tachycardia (SVT). It has a rapid onset of action (within seconds) and an extremely short half-life (less than 10 seconds), making it ideal for acute conversion of SVT to sinus rhythm.
Decision Algorithm for Tachycardia Management
Initial Assessment:
- For hemodynamically unstable patients: Immediate synchronized cardioversion 1
- For hemodynamically stable patients with regular tachycardia: Proceed with pharmacologic management
First-line Therapy:
- Vagal maneuvers (Valsalva, carotid sinus massage) 1
- If unsuccessful, proceed to adenosine
Adenosine Administration:
- Initial dose: 6 mg rapid IV push followed by saline flush
- If ineffective, give 12 mg IV push (can repeat once if needed)
- Adenosine is particularly effective for:
- AV nodal reentrant tachycardia (AVNRT)
- AV reentrant tachycardia (AVRT)
- Sinus node reentry tachycardia 1
Why Not Flecainide or Digoxin?
Flecainide (Option B):
Digoxin (Option C):
- Ineffective for acute conversion to sinus rhythm 1
- Only slows ventricular rate without converting to sinus rhythm in most cases
- Guidelines specifically state: "In patients with AF following cardiac surgery, we cannot at this time recommend using flecainide, digoxin, or calcium channel blockers for the purpose of conversion to sinus rhythm" 1
- Conversion rates with digoxin are similar to placebo, consistent with the self-limited natural history of some arrhythmias rather than drug efficacy 1
Special Considerations
Caution with adenosine:
- Brief side effects may include flushing, chest discomfort, and transient asystole
- Contraindicated in patients with severe asthma or advanced AV block
- Should be used with caution in patients with severe coronary artery disease 1
Alternative options if adenosine fails or is contraindicated:
- IV beta-blockers (e.g., metoprolol)
- IV calcium channel blockers (e.g., verapamil, diltiazem)
- IV amiodarone (particularly in patients with heart failure) 1
Monitoring during administration:
- Continuous ECG monitoring is essential
- Have resuscitation equipment immediately available
- Be prepared for potential transient asystole
In conclusion, adenosine is the most appropriate choice for rapidly converting a patient with a heart rate of 180 bpm to sinus rhythm due to its rapid onset, high efficacy in SVT, and excellent safety profile when used appropriately.